Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Fibirnogen Like Protein 2 as Aprognostic Factor in High Grade Glioma

NCT04113278 is registered in ClinicalTrials.gov with sohaila Essam as lead sponsor.

NCT NCT04113278
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04113278 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Fibirnogen Like Protein 2 as Aprognostic Factor in High Grade Glioma
Lead sponsor
sohaila Essam
Phase
Observational
Overall status
Unknown status
Start date
November 1, 2019
Completion date
September 1, 2021
Enrollment
1 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

brain tumor adult